Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.99.3 (
PRE
)
1,923
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phage
P22
defective in gene 24 and harbouring the Oc mutation k5 in OR exhibits a strongly increased c2-repressor synthesis after infection of non-lysogenic S. typhimurium. The repressor synthesis depends strictly on an intact c1 gene. The kinetics of its synthesis, as monitored by polyacrylamide gel electrophoresis, is the same as with
P22
c+, namely a turn off 8-10 min after infection. - After infection of
P22
-lysogenic bacteria with either
P22
24- k5 or
P22
24- k5 c1, much lower amounts of repressor are synthesized but again with the same kinetics. These results suggest a cro-like function acting at
PRE
and PRM of
P22
. The possible reason for the c2 overproduction is discussed.
...
PMID:Kinetics of c2-repressor synthesis in a regulatory defective P22 mutant. 703 85
The C1 protein of bacteriophage
P22
binds to a unique site in the -35 region of the
PRE
promoter and activates transcription of the phage c2 repressor gene. This -35 target has an approximate direct repeat that overlaps the 5' end of the c1 coding region. We have isolated a single-base-pair mutation in this region that changes the
PRE
-35 target as well as the amino-terminal region of the C1 protein. Although the mutant C1 protein activates the mutant
PRE
promoter, it fails to activate the wild-type
PRE
promoter. This suggests that a single-base-pair mutation changes the specificities of both a protein and its target site. These studies also indicate that C1 binding to DNA is influenced by contacts made through residues near the amino terminus.
...
PMID:A single-base-pair mutation changes the specificities of both a transcription activation protein and its binding site. 841 41